180 Life Sciences Unveils Ambitious $425 Million Private Placement to Establish ETHZilla Treasury Strategy

180 Life Sciences Announces Major Strategic Shift to Ethereum

180 Life Sciences Corp. (Nasdaq: ATNF) is taking a bold step into the cryptocurrency space with plans to launch a new treasury strategy focused on Ethereum (ETH). This development comes as part of a $425 million private investment in public equity (PIPE), which is designed to enhance the company's treasury holdings and facilitate a rebranding to ETHZilla Corporation.

Overview of the PIPE Transaction

The announcement reveals that the pipeline transaction seeks to attract significant funding through the sale of common stock and pre-funded warrants. Investors will enjoy registration rights as part of this arrangement. The deal is expected to close around August 1, 2025, contingent upon customary closing conditions being met.

As part of this strategy, the company has obtained permission to issue up to $150 million in debt securities, with plans to announce an additional offering post-closing of the PIPE. The proceeds from this transaction are primarily earmarked for acquiring ETH, alongside covering corporate expenses and transaction costs.

Institutional Support and New Leadership

A notable aspect of this venture is the robust backing from over 60 institutional and cryptocurrency-focused investors. This includes prominent names such as Harbour Island, Electric Capital, and Polychain Capital, among others. With the expected shift in leadership, McAndrew Rudisill is set to lead as chairman of the board of directors at the close of this transaction.

Rudisill highlighted the immense market cap of Ethereum, which stands at over $450 billion, emphasizing the potential for innovative financial options that could benefit investors.

Strategic Partnerships

Electric Capital will serve as the external asset manager post-deal, and it plans to implement a unique on-chain yield generation program. This initiative aims to outperform traditional Ethereum staking while maintaining strict risk management through various strategies including staking, lending, and liquidity provisioning.

Blair Jordan, the current CEO of 180 Life Sciences, expressed confidence in this strategic move, emphasizing the company's commitment to a sustainable, long-term investment approach supported by a skilled team.

Community Engagement and Long-Term Objectives

180 Life Sciences, soon to be ETHZilla, plans to serve as a treasury management standard for public companies. By focusing on on-chain treasury strategies, ETHZilla aims to empower community investors and provide easy access to Ethereum’s promising ecosystem. The strategic advisory team will consist of both traditional finance experts and pioneering figures within the defi and Ethereum communities.

A DeFi Council made up of leaders within the space will guide ETHZilla’s treasury use, ensuring their strategies positively impact the broader Ethereum ecosystem. This alignment aims to bolster both the company’s growth and the development of the Ethereum network as it approaches its ten-year anniversary.

Investment Benefits and Opportunities

The imminent pipeline transaction is expected to yield immediate value for shareholders with plans to acquire ETH and leverage this for generating yields. The anticipated collaboration with Etherealize is expected to enhance market presence and strategic communications for the new treasury strategy.

In summary, 180 Life Sciences' forthcoming ambition to rebrand as ETHZilla represents a significant pivot towards leveraging cryptocurrency for innovation in treasury management. This venture marks a proactive step to align with evolving market trends and investor demands, potentially positioning ETHZilla as a key player in the burgeoning Ethereum landscape.